Breaking age barriers: the efficacy of ERCP in advanced age patients

Zhuang Li(Chinese Academy of Social Sciences), Minghui Sheng(JiangSu Armed Police General Hospital), Yanjun Sun(JiangSu Armed Police General Hospital), Wenfei Wang(Northeast Agricultural University), Zhenyu Qiao(JiangSu Armed Police General Hospital), Dengqun Sun(Chinese People's Armed Police Force)
BMC Surgery
August 6, 2025
10.1186/s12893-025-03083-5
Cited by 2

Related Papers

Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway
|International Immunopharmacology|2015|74
Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy
|Journal of Pharmacological Sciences|2016|46
Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy
|Postgraduate Medicine|2024|18
Clinical application of indocyanine green fluorescence navigation technique in laparoscopic common bile duct exploration for complex hepatolithiasis
|BMC Surgery|2024|9
227P Efficacy of conversional radical surgery following upfront docetaxel, oxalipaltin and S1 (DOS) regimen for advanced gastric cancer with a single non-curable factor
|Annals of Oncology|2016|0